Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Retroviruses differ in their preferences for sites for viral DNA integration in the chromosomes of infected cells. Human immunodeficiency virus (HIV) integrates preferentially within active transcription units, whereas murine leukemia virus (MLV) integrates preferentially near transcription start sites and CpG islands. We investigated the viral determinants of integration-site selection using HIV chimeras with MLV genes substituted for their HIV counterparts. We found that transferring the MLV integrase (IN) coding region into HIV (to make HIVmIN) caused the hybrid to integrate with a specificity close to that of MLV. Addition of MLV gag (to make HIVmGagmIN) further increased the similarity of target-site selection to that of MLV. A chimeric virus with MLV Gag only (HIVmGag) displayed targeting preferences different from that of both HIV and MLV, further implicating Gag proteins in targeting as well as IN. We also report a genome-wide analysis indicating that MLV, but not HIV, favors integration near DNase I-hypersensitive sites (i.e., +/- 1 kb), and that HIVmIN and HIVmGagmIN also favored integration near these features. These findings reveal that IN is the principal viral determinant of integration specificity; they also reveal a new role for Gag-derived proteins, and strengthen models for integration targeting based on tethering of viral IN proteins to host proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Retroviral DNA Integration and the Chimeric Viruses Used in This Study (A) The DNA breaking and joining reactions mediating integration. Gray ovals represent integrase monomers, thick red lines represent viral DNA, black lines represent target DNA, and dots represent 5′ ends. (1) Linear blunt-ended viral cDNA is bound by integrase as part of the preintegration complex. (2) Integrase removes two nucleotides from the 3′ ends of the viral DNA, exposing recessed 3′ hydroxyl groups. (3) IN joins the recessed 3′ ends of viral DNA to the target DNA. (4) Unpairing of the target DNA between the joined ends of the viral DNA yields gaps in the target DNA. (5) DNA repair enzymes fill in the gaps. (6) The provirus is flanked by repeated segments of the target DNA. (B) Chimeric HIV derivatives containing segments of MLV. At the top is the HIV parent virus, with vpr and env inactivated and the puromycin resistance gene in place of nef. Following that are the chimeras, with substitutions of MLV gag gene segments (MA-, p12-, and CA-encoding regions) for HIV MA and CA, or substitution of MLV IN for HIV IN, or both [20,21]. The MLV genome (indicated by an asterisk) is shown for comparison. The MLV used in this study (MLVPuro) was an MLV-based vector (LPCX) encoding the puromycin resistance gene with Gag, Pol, and Env provided in trans. Although we refer to “Gag” in the text, we note that Gag is in fact a polyprotein which is cleaved into individual functional proteins by the action of the viral protease. (C) Target-sequence duplication lengths made by HIV, MLV, and the chimeric viruses. (D) Primary sequences at the site of integration for HIV, MLV, the chimeric viruses, and a previously published MLV dataset (MLV-Burgess). On the x-axis are the top strand positions surrounding the point of integration, which is represented by the blue arrow and line (between positions −1 and 0). For each dataset, the proportion of each base at a given location was divided by the proportion of that base in the matched random control set, such that a base with a y value >1 is present at an increased frequency, while a base with a y value <1 is present at a decreased frequency compared to random sites. A dashed red box surrounds the target sequence that is duplicated upon integration.](https://figures.cochat.ai/paper-figures/05f7d0bde8fb47e2ad42ba2f8a012e93/retroviral-dna-integration-viral-and-cellular-determinants-of-target-site-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, proviral integration in the transcriptionally active regions could potentially favor expression of the viral genes, whereas integration in the transcriptionally silent regions (heterochromatin) may not be in favor of viral expression and may even force the virus to stay transcriptionally silent (Jordan et al. 2001, Lewinski et al. 2006, Einkauf et al. 2022, Teixeira et al. 2024).”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, it is now becoming clearer that certain retroviruses like HIV tend to target gene-rich, transcriptionally active, euchromatic regions within the host’s chromosome to integrate.”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, it has been suggested that Gag-derived protein(s), especially CA, plays an important role during retroviral integration.”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence toward this has been drawn from experiments that have shown that mutations in HIV-1 CA and its interactions with cyclophilin do not inhibit viral integration but favor integration into the genomic regions that are not transcriptionally active, as opposed to wild-type virus typically integrating into the transcriptionally active regions (Lewinski et al. 2006, Schaller et al. 2011, Engelman”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The gammaretrovirus MLV exhibits preferential insertion near transcriptional start sites, while the lentivirus HIV preferentially inserts within transcriptional units.”
From Clinical use of lentiviral vectors (2018) · cites this paper as [17]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 1×
“The integration frequency near CpG islands was then compared. CpG islands are regions rich in the CpG dinucleotide, which are undermethylated and frequently associated with gene regulatory regions [”
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“The recent setbacks in human gene-therapy trials, in which a therapeutic retroviral vector integrated near the LMO-2 proto-oncogene and caused leukemia-like illness in three patients [1–3], have focused particular attention on the mechanisms responsible”
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-citationTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 9×
“MLV strongly favors integration near CpG islands while HIV does not [11,14].”
Influential(2007) · Wiley eBooks · doi:10.1128/9781555817954 · Cited by 1,291
NUCLEASE HYPERSENSITIVE SITES IN CHROMATIN
Gross, D. S., & Garrard, W. T. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001111 · Cited by 1,233
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Self-citationIntegration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Self-citation
Cited by
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Self-citationClinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
“Each class of retrovirus has its characteristic preference [17, 18].”
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
Karimi, M. M., Goyal, P., Maksakova, I. A., Bilenky, M., Leung, D., Tang, J. X., Shinkai, Y., Mager, D. L., Jones, S., Hirst, M., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.004 · Cited by 535
Shun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467
“Analyses of MLV/HIV chimerae have revealed that IN is the primary viral determinant governing integration site selection (Lewinski et al. 2006).”
Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., & Bushman, F. D. (2007) · Genome Research · doi:10.1101/gr.6286907 · Cited by 457
“HIV favors integration within active transcription units (Schroder et al. 2002; Wu et al. 2003; Mitchell et al. 2004; Barr et al. 2005, 2006; Ciuffi et al. 2005, 2006b; Lewinski et al. 2005, 2006).”
Self-citationHIV-1 Integration Landscape during Latent and Active Infection
Cohn, L. B., Silva, I. T., Oliveira, T. Y., Rosales, R. A., Parrish, E. H., Learn, G. H., Hahn, B. H., Czartoski, J. L., McElrath, M. J., Lehmann, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.020 · Cited by 444
“TG-(N)5-7-CA sequence has been associated with sites of HIV-1 integration, but an integration consensus has not been defined (Brady et al., 2009; Holman and Coffin, 2005; Lewinski et al., 2006; Serrao et al., 2014; Wang et al., 2007; Wu et al., 2005).”
Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression
Karn, J., & Stoltzfus, C. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006916 · Cited by 437
“When HIV-1 infects cells, it preferentially integrates into active transcription units that provide a favorable environment for viral transcription (Lewinski et al. 2006).”
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
Kotterman, M. A., Chalberg, T. W., & Schaffer, D. V. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104938 · Cited by 424
Modlich, U., Navarro, S., Zychlinski, D., Maetzig, T., Knoess, S., Brugman, M. H., Schambach, A., Charrier, S., Galy, A., Thrasher, A. J., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.179 · Cited by 387
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
“In this study, the IN region of the gammaretrovirus MLV was substituted for that of HIV, and integration target site selection monitored (Lewinski et al. 2006).”
Self-citationAn Integrated Overview of HIV-1 Latency
Ruelas, D. S., & Greene, W. C. (2013) · Cell · doi:10.1016/j.cell.2013.09.044 · Cited by 324
Pearson, R., Kim, Y. K., Hokello, J., Lassen, K., Friedman, J., Tyagi, M., & Karn, J. (2008) · Journal of Virology · doi:10.1128/jvi.01383-08 · Cited by 297
“As expected from the extensive studies characterizing HIV proviral integration sites (33, 34, 38), the majority of clones were located in intronic regions of host genes.”
Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2
Friedman, J., Cho, W.-K., Chu, C. K., Keedy, K. S., Archin, N. M., Margolis, D. M., & Karn, J. (2011) · Journal of Virology · doi:10.1128/jvi.00836-11 · Cited by 284
“Although most latent HIV-1 proviruses are found integrated into actively transcribed genes (28, 48), latent HIV-1 proviruses characteristically acquire heterochromatic structures.”
Integration site selection by retroviruses and transposable elements in eukaryotes
Sultana, T., Zamborlini, A., Cristofari, G., & Lesage, P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.7 · Cited by 275
Next-generation stem cells — ushering in a new era of cell-based therapies
Kimbrel, E. A., & Lanza, R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0064-x · Cited by 275
Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241
“In support of this idea is the finding that MLV integration is strongly favored at start sites [28,57], while several other integrating elements show near random distributions [22,55,58], suggesting that mechanisms exist to guide preferential integration near start sites.”
Self-citationLesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Mbonye, U., & Karn, J. (2014) · Virology · doi:10.1016/j.virol.2014.02.008 · Cited by 228
“HIV preferentially integrates within intragenic regions of actively transcribed regions of the host genome (Lewinski et al., 2006).”
Colin, L., & Van Lint, C. (2009) · Retrovirology · doi:10.1186/1742-4690-6-111 · Cited by 222
“Following nuclear import, LEDGF/p75, a transcriptional coactivator which interacts directly with the viral integrase [54], targets the PIC predominantly to intronic regions of actively transcribed genes [55-57].”
Biffi, A., Bartolomae, C. C., Cesana, D., Cartier, N., Aubourg, P., Ranzani, M., Cesani, M., Benedicenti, F., Plati, T., Rubagotti, E., et al. (2011) · Blood · doi:10.1182/blood-2010-09-306761 · Cited by 216
HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001313 · Cited by 212
“We previously studied integration targeting in HeLa cells using HIV chimeras containing MLV gag, MLV IN, or both, in place of their HIV counterparts [40].”
Self-citationChromodomains direct integration of retrotransposons to heterochromatin
Gao, X., Hou, Y., Ebina, H., Levin, H. L., & Voytas, D. F. (2008) · Genome Research · doi:10.1101/gr.7146408 · Cited by 205
“…integrase were swapped demonstrated that integrase is responsible for the different patterns of integration observed at genes for these two viruses (Lewinski et al. 2006), and in a separate study, sequence differences among various retroviral integrases were found to correlate with global and…”
Hindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
Selection of Target Sites for Mobile DNA Integration in the Human Genome
Berry, C., Hannenhalli, S., Leipzig, J., & Bushman, F. D. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020157 · Cited by 201
“The effects of selection were prominent in the comparison of the two MLV datasets, as described previously [16] and analyzed in more detail here.”
InfluentialSelf-citationNuclear landscape of HIV-1 infection and integration
Lušić, M., & Siliciano, R. F. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.162 · Cited by 201
Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges
Cavazzana, M., Bushman, F. D., Miccio, A., André-Schmutz, I., & Six, E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0020-9 · Cited by 199
Self-citationBET proteins promote efficient murine leukemia virus integration at transcription start sites
Sharma, A., Larue, R. C., Plumb, M. R., Malani, N., Male, F., Slaughter, A., Kessl, J. J., Shkriabai, N., Coward, E., Aiyer, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307157110 · Cited by 193
“To delineate the Brd3(1-726) segments (Fig.”
InfluentialSelf-citationThe Role of Macrophages in HIV-1 Persistence and Pathogenesis
Kruize, Z., & Kootstra, N. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02828 · Cited by 193
Karn, J. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328340ffbb · Cited by 184
Battivelli, E., Dahabieh, M. S., Abdel-Mohsen, M., Svensson, J. P., Tojal Da Silva, I., Cohn, L. B., Gramatica, A., Deeks, S., Greene, W. C., Pillai, S. K., et al. (2018) · eLife · doi:10.7554/elife.34655 · Cited by 184
“…et al., 2005) in which HIV-1 preferentially integrates into active genes (Barr et al., 2006; Bushman et al., 2005; Demeulemeester et al., 2015; Ferris et al., 2010; Han et al., 2004; Lewinski et al., 2006; Mitchell et al., 2004; Schröder et al., 2002; Sowd et al., 2016; Wang et al., 2007).”
Gene therapy for severe combined immunodeficiency: are we there yet?
Cavazzana-Calvo, M., & Fischer, A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30953 · Cited by 183
Moiani, A., Paleari, Y., Sartori, D., Mezzadra, R., Miccio, A., Cattoglio, C., Cocchiarella, F., Lidonnici, M. R., Ferrari, G., & Mavilio, F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61852 · Cited by 183
“The host cell factor LEDGF/p75 has a major role in tethering HIV preintegration complexes to active genes by directly binding the viral integrase (5), a major viral determinant of target-site selection (6).”
Gammaretroviral Vectors: Biology, Technology and Application
Maetzig, T., Galla, M., Baum, C., & Schambach, A. (2011) · Viruses · doi:10.3390/v3060677 · Cited by 184
“However, due to the semi-random insertion profile of retroviral vectors, selective intergenic insertions may be difficult to obtain: Gammaretroviruses cluster in the proximity of the transcriptional start site, CpG islands and DNaseI hypersensitive sites, lentiviruses integrate within the whole transcription unit, and…”
The Molecular Basis for Human Immunodeficiency Virus Latency
Mbonye, U., & Karn, J. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041646 · Cited by 182
“HIV preferentially integrates within introns of actively transcribed host genes (121), but its chromatin structure and transcription are controlled independently.”
Christ, F., Shaw, S., Demeulemeester, J., Desimmie, B. A., Marchand, A., Butler, S., Smets, W., Chaltin, P., Westby, M., Debyser, Z., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00717-12 · Cited by 176
“Integration into host DNA is not random and occurs at preferred sites that are associated with active transcription (25, 47).”
De Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F. D., Landuyt, B., Husson, S. J., Busschots, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.040 · Cited by 175
Self-citationBiosafety Features of Lentiviral Vectors
Schambach, A., Zychlinski, D., Ehrnstroem, B., & Baum, C. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.229 · Cited by 173
“Attempts to redirect the lentiviral pattern involve the introduction of LEDGF mutants into the target cells (Gijsbers et al., 2010) and the direct modification of the integrase (Lewinski et al., 2006).”
Derse, D., Crise, B., Li, Y., Princler, G., Lum, N., Stewart, C., McGrath, C. F., Hughes, S. H., Munroe, D. J., & Wu, X. (2007) · Journal of Virology · doi:10.1128/jvi.02752-06 · Cited by 173
“We believe that the effect of drug selection will be modest, both because the time of selection is relatively short (2 weeks) and because previous studies have demonstrated that a short-term drug selection did not significantly affect the populations of recovered integration sites (34).”
InfluentialHIV integration site distributions in resting and activated CD4 + T cells infected in culture
Brady, T., Agosto, L. M., Malani, N., Berry, C. C., O'Doherty, U., & Bushman, F. (2009) · AIDS · doi:10.1097/qad.0b013e32832caf28 · Cited by 145
“This method for generating matched random controls accounts for biases in the recovery of integration sites based on their proximity to MseI sites and allows for more accurate statistical analysis [18,21,22,29–31].”
Self-citationHIV-1 Pre-Integration Complexes Selectively Target Decondensed Chromatin in the Nuclear Periphery
Albanese, A., Arosio, D., Terreni, M., & Cereseto, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002413 · Cited by 138
Viral Vectors: The Road to Reducing Genotoxicity
David, R. M., & Doherty, A. T. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw220 · Cited by 170
Cattoglio, C., Pellin, D., Rizzi, E., Maruggi, G., Corti, G., Miselli, F., Sartori, D., Guffanti, A., Di Serio, C., Ambrosi, A., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283523 · Cited by 168
Integrase, LEDGF/p75 and HIV replication
Poeschla, E. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7540-5 · Cited by 165
Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
Ferris, A. L., Wu, X., Hughes, C. M., Stewart, C., Smith, S. J., Milne, T. A., Wang, G. G., Shun, M.-C., Allis, C. D., Engelman, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914142107 · Cited by 141
Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
“Interestingly, these chimeric viruses displayed reduced integration frequencies in gene rich regions, which suggested a Gag-dependent role in integration site targeting (13,144,146).”
Genome-wide Mapping of PiggyBac Transposon Integrations in Primary Human T Cells
Galvan, D. L., Nakazawa, Y., Kaja, A., Kettlun, C., Cooper, L. J. N., Rooney, C. M., & Wilson, M. H. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b2914c · Cited by 131
HIV reservoirs, latency, and reactivation: Prospects for eradication
Dahl, V., Josefsson, L., & Palmer, S. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.016 · Cited by 143
Mechanisms of Retroviral Integration and Mutagenesis
Cavazza, A., Moiani, A., & Mavilio, F. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.203 · Cited by 125
“Other components of the PIC, such as glucosaminoglycan (GAG) polypeptides, play a minor but detectable role in the process (Lewinski et al., 2006).”
InfluentialGupta, S. S., Maetzig, T., Maertens, G. N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., & Schulz, T. F. (2013) · Journal of Virology · doi:10.1128/jvi.01942-13 · Cited by 139
“To clone FLAG-tagged deletion constructs for MLV IN, IN fragments were PCR amplified from pQMLV-IN-FLAG plasmid using the following primer pairs: IN(110-409) ( NTD), SG1 and PC595; IN(160-409) ( CCD), SG2 and PC595; IN(1-278) ( CTD), PC594 and SG3; IN(160359) ( CCD CTD), SG2 and SG4.”
Retroviral integration and human gene therapy
Bushman, F. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32949 · Cited by 138
Self-citationHigh-throughput insertional mutagenesis screens in mice to identify oncogenic networks
Kool, J., & Berns, A. J. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2647 · Cited by 137
Integration target site selection by a resurrected human endogenous retrovirus
Brady, T., Lee, Y. N., Ronen, K., Malani, N., Berry, C. C., Bieniasz, P. D., & Bushman, F. D. (2009) · Genes & Development · doi:10.1101/gad.1762309 · Cited by 120
“MLV strongly favored integration near CpG islands (>15-fold) and DNase sites (Wu et al. 2003; Berry et al. 2006; Lewinski et al. 2006).”
InfluentialSelf-citationINSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes
Sherman, E., Nobles, C., Berry, C. C., Six, E., Wu, Y., Dryga, A., Malani, N., Male, F., Reddy, S., Bailey, A., et al. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.002 · Cited by 124
Self-citationWang, G. P., Berry, C. C., Malani, N., Leboulch, P., Fischer, A., Hacein-Bey-Abina, S., Cavazzana-Calvo, M., & Bushman, F. D. (2010) · Blood · doi:10.1182/blood-2009-12-257352 · Cited by 123
Self-citationInsertional mutagenesis in gene therapy and stem cell biology
Baum, C. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3281900f01 · Cited by 108
Meekings, K. N., Leipzig, J., Bushman, F. D., Taylor, G. P., & Bangham, C. R. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000027 · Cited by 114
“The different targeting preferences of the individual retroviruses are determined by several known factors, including the properties of the viral integrase [12], DNA binding proteins [13,14], cellular targeting proteins [15–19] and the chromatin structure at the point of integration [20,21].”
Self-citationLarge-scale gene trapping in C57BL/6N mouse embryonic stem cells
Hansen, G. M., Markesich, D. C., Burnett, M. B., Zhu, Q., Dionne, K. M., Richter, L. J., Finnell, R. H., Sands, A. T., Zambrowicz, B. P., & Abuin, A. (2008) · Genome Research · doi:10.1101/gr.078352.108 · Cited by 121
Koh, Y., Wu, X., Ferris, A. L., Matreyek, K. A., Smith, S. J., Lee, K., KewalRamani, V. N., Hughes, S. H., & Engelman, A. (2013) · Journal of Virology · doi:10.1128/jvi.01148-12 · Cited by 122
“Prior studies of the effects of CA mutations have focused on the distribution of integration sites (32, 34).”
InfluentialTiteux, M., Pendaries, V., Zanta-Boussif, M. A., Décha, A., Pironon, N., Tonasso, L., Mejia, J. E., Brice, A., Danos, O., & Hovnanian, A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.91 · Cited by 111
Host and viral determinants for MxB restriction of HIV-1 infection
Matreyek, K. A., Wang, W., Serrao, E., Singh, P. K., Levin, H. L., & Engelman, A. (2014) · Retrovirology · doi:10.1186/s12977-014-0090-z · Cited by 103
“As expected [41,46], HIV-1 additionally favored integration into chromosomal regions that were relatively enriched in genes: as compared to the calculated MRC value of 8.”
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
Wu, C., & Dunbar, C. E. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0159-1 · Cited by 114
A reversible gene trap collection empowers haploid genetics in human cells
Bürckstümmer, T., Banning, C., Hainzl, P., Schobesberger, R., Kerzendorfer, C., Pauler, F. M., Chen, D., Them, N., Schischlik, F., Rebsamen, M., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2609 · Cited by 105
“Majdic (Institute of Immunology, Medical University of Vienna) and used for stainings (clone): MHC-I (W6/32), CD3 (VIT3b), CD11a (CD11a-5E6), CD11b (VIM12), CD13 (5-390), CD34 (9F2), CD40 (G28-5), CD44 (3F5), CD45 (VIT200), CD47 (AIV), CD63 (11C9 15), CD71 (VIP1) and CD147 (AAA1).”
Kim, S., Kim, N., Dong, B., Boren, D., Lee, S. A., Das Gupta, J., Gaughan, C., Klein, E. A., Lee, C., Silverman, R. H., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01299-08 · Cited by 105
“For instance, binding sites for the AP-1 and Bach1 transcription factors are enriched near MLV integration sites (58), and HIV-1 integration site pattern is altered by the absence or presence of the LEDGF/p75 transcription factor (21, 90).”
InfluentialToll-like receptor 3 activation selectively reverses HIV latency in microglial cells
Alvarez-Carbonell, D., Garcia-Mesa, Y., Milne, S., Das, B., Dobrowolski, C., Rojas, R., & Karn, J. (2017) · Retrovirology · doi:10.1186/s12977-017-0335-8 · Cited by 99
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
Wang, G. P., Garrigue, A., Ciuffi, A., Ronen, K., Leipzig, J., Berry, C., Lagresle-Peyrou, C., Benjelloun, F., Hacein-Bey-Abina, S., Fischer, A., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn125 · Cited by 100
Self-citationFelice, B., Cattoglio, C., Cittaro, D., Testa, A., Miccio, A., Ferrari, G., Luzi, L., Recchia, A., & Mavilio, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004571 · Cited by 101
“To provide evidence for a role of the MLV integrase in directing integration to TFBS-rich regions, we carried out a comparative analysis of the sequences flanking the integration sites of an MLV vector [3], an HIV vector [19], and an HIV vector packaged with an MLV integrase (HIVmIN) [19], in HeLa cells.”
InfluentialCellular and molecular mechanisms of HIV-1 integration targeting
Engelman, A., & Singh, P. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2772-5 · Cited by 113
“The use of such constructs first indicated a role for HIV-1 Gag, the polyprotein that includes capsid, in integration targeting [127].”
Biasco, L., Ambrosi, A., Pellin, D., Bartholomae, C., Brigida, I., Roncarolo, M. G., Di Serio, C., von Kalle, C., Schmidt, M., & Aiuti, A. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000108 · Cited by 104
“Percentage of transduced cells were calculated on the basis of a standard curve and expressed as proportion of cells carrying the NeoR gene.”
InfluentialmiRNA cassettes in viral vectors: Problems and solutions
Liu, Y. P., & Berkhout, B. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.014 · Cited by 109
Gillet, N. A., Gutiérrez, G., Rodriguez, S. M., de Brogniez, A., Renotte, N., Alvarez, I., Trono, K., & Willems, L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003687 · Cited by 96
“These preferences originate from the structure of the pre-integration complex given by the viral integrase [31,32], its possible cellular partners [33] and from the relative accessibility of the genome [30].”
Mouse Mammary Tumor Virus Integration Site Selection in Human and Mouse Genomes
Faschinger, A., Rouault, F., Sollner, J., Lukas, A., Salmons, B., Günzburg, W. H., & Indik, S. (2008) · Journal of Virology · doi:10.1128/jvi.02098-07 · Cited by 97
AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
M. Mitchell, A., C. Nicolson, S., K. Warischalk, J., & Jude Samulski, R. (2010) · Current Gene Therapy · doi:10.2174/156652310793180706 · Cited by 96
“Conversely, lentiviral vectors still demonstrate the possibility of insertional mutagenesis [53], are subject to transgene silencing and variation due to integration site [54], are subject to innate immune responses and to preexisting immunity to the pseudotyped proteins [55], lack scalable production, and have diffic…”
Heinz, N., Schambach, A., Galla, M., Maetzig, T., Baum, C., Loew, R., & Schiedlmeier, B. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.099 · Cited by 101
Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
Pike‐Overzet, K., Rodijk, M., Ng, Y.-Y., Baert, M. R. M., Lagresle‐Peyrou, C., Schambach, A., Zhang, F., Hoeben, R. C., Hacein‐Bey‐Abina, S., Lankester, A. C., et al. (2011) · Leukemia · doi:10.1038/leu.2011.106 · Cited by 99
Wang, C. X., Sather, B. D., Wang, X., Adair, J., Khan, I., Singh, S., Lang, S., Adams, A., Curinga, G., Kiem, H.-P., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546218 · Cited by 88
Hybrid Lentivirus-transposon Vectors with a Random Integration Profile in Human Cells
Staunstrup, N. H., Moldt, B., Mátés, L., Villesen, P., Jakobsen, M., Ivics, Z., Izsvák, Z., & Mikkelsen, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.10 · Cited by 96
Yuen, G., Khan, F. J., Gao, S., Stommel, J. M., Batchelor, E., Wu, X., & Luo, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx843 · Cited by 94
“Because retroviral insertion tends to target open regions of the genome (26), our model may not reflect the behavior of CRISPR at heterochromatin target sites.”
Mularoni, L., Zhou, Y., Bowen, T., Gangadharan, S., Wheelan, S. J., & Boeke, J. D. (2012) · Genome Research · doi:10.1101/gr.129460.111 · Cited by 77
“Such deviations from randomness are now well known for virtually every transposable element examined in detail (Waddell and Craig 1989; Bender and Kleckner 1992; Liao et al. 2000; Barr et al. 2006; Lewinski et al. 2006; Wang et al. 2007; Gangadharan et al. 2010; Guo and Levin 2010).”
Interactions between Retroviruses and the Host Cell Genome
Poletti, V., & Mavilio, F. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.10.001 · Cited by 93
“packaged with MLV Gag proteins had suggested that other components of the PIC, in particular the p12 Gag protein, may have a role in MLV target site selection.(71) The MLV p12 is a constituent of the PIC, but its function in the complex remains ill-defined.”
Lesbats, P., Botbol, Y., Chevereau, G., Vaillant, C., Calmels, C., Arneodo, A., Andreola, M.-L., Lavigne, M., & Parissi, V. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001280 · Cited by 71
“the integrase protein appears to be the principle viral determinant responsible for this differential DNA targeting during integration [18].”
Moldt, B., Miskey, C., Staunstrup, N. H., Gogol‐Döring, A., Bak, R. O., Sharma, N., Mátés, L., Izsvák, Z., Chen, W., Ivics, Z., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.47 · Cited by 90
Use of HIV as a gene transfer vector.
Pluta, K. D., & Kacprzak, M. M. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2490 · Cited by 89
“This discrepancy in the integration site selection between simple retroviruses and their more complex relatives could be explained by the different interactions of host cellular factors with viral integrase (IN) and Gag-derived proteins (Lewinski et al., 2006).”
Integration Site Selection by Retroviral Vectors: Molecular Mechanism and Clinical Consequences
Daniel, R., & Smith, J. A. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.148 · Cited by 73
“Integration seems to be disfavored in the vicinity of H3K27 trimethylation (H3K27Me3) and CpG islands in the DNA (see text and Wang et al ., 2007). determinant of integration site selection (Lewinski et al ., 2006).”
InfluentialImproving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 86
Viral causes of feline lymphoma: Retroviruses and beyond
Beatty, J. A. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.05.026 · Cited by 85
Non-Integrating Lentiviral Vectors
Sarkis, C., Philippe, S., Mallet, J., & Serguera, C. (2008) · Current Gene Therapy · doi:10.2174/156652308786848012 · Cited by 74
Li, X., Ewis, H. E., Hice, R. H., Malani, N., Parker, N., Zhou, L., Feschotte, C., Bushman, F. D., Atkinson, P. W., & Craig, N. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121543109 · Cited by 81
Self-citationSize matters: versatile use of PiggyBac transposons as a genetic manipulation tool
Kim, A., & Pyykkö, I. V. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0832-3 · Cited by 80
The cell biology of HIV-1 and other retroviruses
Freed, E. O., & Mouland, A. J. (2006) · Retrovirology · doi:10.1186/1742-4690-3-77 · Cited by 60
Shun, M.-C., Botbol, Y., Li, X., Di Nunzio, F., Daigle, J. E., Yan, N., Lieberman, J., Lavigne, M., & Engelman, A. (2008) · Journal of Virology · doi:10.1128/jvi.01561-08 · Cited by 78
“Analyses of Moloney murine leukemia virus/HIV-1 chimera viruses revealed that the cognate integrase protein principally determines local DNA sequence and genetic structure specificities during integration ( 25 ).”
Retroviral integration site selection
Desfarges, S., & Ciuffi, A. (2010) · Viruses · doi:10.3390/v2010111 · Cited by 78
Self-citationFigueroa, J. A., Reidy, A., Mirandola, L., Trotter, K., Suvorava, N., Figueroa, A., Konala, V., Aulakh, A., Littlefield, L., Grizzi, F., et al. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1018419 · Cited by 78
Human Immunodeficiency Virus (HIV) Latency: The Major Hurdle in HIV Eradication
Tyagi, M., & Bukrinsky, M. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00194 · Cited by 78
Viral Integration and Consequences on Host Gene Expression
Desfarges, S., & Ciuffi, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-4899-6_7 · Cited by 80
“The fi rst one takes advantage of chimeric constructs between MLV and HIV-1, and the subsequent analysis of integration site distribution (Lewinski et al. 2006 ) .”
Self-citationHIV-1 capsid is involved in post-nuclear entry steps
Chen, N.-Y., Zhou, L., Gane, P. J., Opp, S., Ball, N. J., Nicastro, G., Zufferey, M., Buffone, C., Luban, J., Selwood, D., et al. (2016) · Retrovirology · doi:10.1186/s12977-016-0262-0 · Cited by 68
“Some capsid mutations promote autointegration of the viral genome [14] whereas other changes in capsid or Gag alter the distribution of HIV-1 integrations sites [15, 16].”
p12 Tethers the Murine Leukemia Virus Pre-integration Complex to Mitotic Chromosomes
Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N., & Bacharach, E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003103 · Cited by 76
“Also, the lens epithelium-derived growth factor (LEDGF/p75), interacts with HIV PICs [11,12] tethers the integrase (IN) of HIV and other lentiviruses to chromatin [11,13,14,15,16], but not the MLV IN [11,17], for which no equivalent tethering factor has been identified. p12, a cleavage product of MLV Gag precursor, is…”
Tipanee, J., Samara-Kuko, E., Gevaert, T., Chuah, M. K., & VandenDriessche, T. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.006 · Cited by 76
Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence
Huang, A. S., Ramos, V., Oliveira, T. Y., Gaebler, C., Janković, M., Nussenzweig, M. C., & Cohn, L. B. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211427 · Cited by 76
Botbol, Y., Raghavendra, N. K., Rahman, S., Engelman, A., & Lavigne, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1127 · Cited by 63
“Analyses of HIV-1/Mo-MLV chimera viruses has revealed integrase as the principle viral determinant responsible for differential gene targeting during integration (16).”
Metadata
- Authors
- Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., Berry, C. C., Ecker, J. R., & Bushman, F. D.
- Affiliations
- Salk Institute for Biological Studies (US)
- Fred Hutch Cancer Center (US)
- University of Pennsylvania (US)
- National Institutes of Health (US)
- University of California San Diego (US)
- Corresponding author
- Bushman, Frederic D
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-06-23
- Volume
- 2
- Issue
- 6
- Pages
- e60
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC1480600
- OpenAlex
- W1980869599
- Cited by
- 364
- References
- 46
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 16 · 2021: 5 · 2020: 9 · 2019: 11 · 2018: 7 · 2017: 18 · 2016: 21 · 2015: 15 · 2014: 26 · 2013: 25 · 2012: 32
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- James B. Pendleton Charitable Trust
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R37AI030927, AI30927, R56AI030927, AI52845, AI 34786, R01AI034786, R01AI030927, R01AI052845)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- retroviral integration, target site selection, HIV, murine leukemia virus, integrase, Gag protein, chimeric viruses, DNase I hypersensitive sites, CpG islands, transcription start sites, host-virus interaction
- MeSH terms
- Attachment Sites, Microbiological, Binding Sites, Chimera, Cloning, Molecular, Deoxyribonuclease I, DNA, Viral, Glycosaminoglycans, HeLa Cells, HIV, Humans, Leukemia Virus, Murine, Puromycin, Retroviridae, Transcription Factors, Transduction, Genetic, Virus Integration, Gene Transfer Techniques, CpG Islands, Integrases, Transcription Initiation Site
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.